Eisai Co., Ltd. ( ESALF) - Stock Earnings
ESALF Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| July 31, 2026, midnight | — / — | — | — / — | — |
ESALF Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q2 | 101.1 million USD | 1.4 billion USD |
| 2025Q3 | 69.6 million USD | 1.4 billion USD |
| 2025Q4 | 109.7 million USD | 1.4 billion USD |
| 2026Q3 Est. | — | — |
ESALF Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 417.3 million USD | 5.6 billion USD |
| 2024 | 280.1 million USD | 4.9 billion USD |
| 2025 | 310.9 million USD | 5.3 billion USD |
| 2026 Est. | — | — |
ESALF
Price: $26.18
Dividend Yield: 4.17%
Forward Dividend Yield: 3.89%
Payout Ratio: 132.31%
Dividend Per Share: 1.02 USD
Earnings Per Share: 0.86 USD
P/E Ratio: 32.56
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: Japan
Market Capitalization: 7.1 billion
Average Dividend Frequency: 2
Years Paying Dividends: 40
DGR3: 8.90%
DGR5: 3.87%
DGR10: 3.25%
DGR20: 7.31%